Stockscreener 앱 받기
0.2533
0.08%
0.0008
Cosmos Health Inc 주식(COSM)의 최신 뉴스
Cosmos Health projects revenue to reach $200.6M by 2029 - Investing.com Canada
Cosmos Health targets $200 mln revenue, $44 mln adjusted EBITDA by 2029 - marketscreener.com
Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029 - TradingView
From $19M loss to $31M profit: Cosmos Health maps 2029 turnaround - Stock Titan
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash G - StreetInsider
Cosmos Health Releases 2026–2029 Guidance: Targeting $200M - GlobeNewswire
Cosmos Health (COSM) Q1 2026: Revenue $17.93M Misses $21.67M Est - GuruFocus
Cosmos Health (NASDAQ: COSM) seeks shareholder votes on equity plan, Series B preferred - Stock Titan
Cosmos Health Q1 2026 Results: Record $17.9M Revenue, Liabilities Down, U.S. Expansion Underway - Minichart
Cosmos Health reports Q1 revenue up 31% to $17.9M; liabilities down $4.5M - TradingView
Cosmos Health (COSM) Q1 revenue up 31% as net loss widens - Stock Titan
Cosmos Health Reports Strong Q1 Results with Record Revenue - GuruFocus
Cosmos Health (COSM) Reports Strong Q1 2026 Revenue Growth - GuruFocus
Cosmos Health’s Series B warrants expire unexercised By Investing.com - Investing.com Nigeria
Cosmos Health’s Series B warrants expire unexercised - Investing.com
Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants - ACCESS Newswire
4.87M Cosmos Health warrants expire with no new shares issued - Stock Titan
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year By Investing.com - Investing.com South Africa
Cosmos Health reports Q1 revenue of $17.9M, up 31% year-over-year - Investing.com Australia
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway - ACCESS Newswire
BRIEF-Cosmos Health Q1 Revenue USD 17.9 Million - TradingView
Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues Into Q2 With U.S. Expansion Underway - 富途牛牛
COSM Shows Rapid Revenue Rise - Yahoo Finance
Cosmos Health Inc. 1Q 2026: Revenue $17.93M, EPS ($0.06) — 10-Q Summary - TradingView
Cosmos Health (NASDAQ: COSM) posts Q1 loss and issues going‑concern warning - Stock Titan
Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt P - ACCESS Newswire
Cosmos Health Company Profile & Introduction - Moomoo
COSM Q1'26 Earnings: EPS estimate is (0.01) USD - TradingView
Cosmos Health Inc stock (US22143K1016): volatility after reverse split and uplisting plans draw inve - AD HOC NEWS
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
[NT 10-Q] Cosmos Health Inc. SEC Filing - Stock Titan
Cosmos Health (COSM) Engages European Investment Bank for R&D Fi - GuruFocus
Cosmos Health stock (US22143K1016): Pursues €25M EIB financing for R&D - AD HOC NEWS
Cosmos Health pursues €25M EIB financing for R&D program By Investing.com - Investing.com South Africa
Cosmos Health pursues €25M EIB financing for R&D program - Investing.com
Cosmos Health regains compliance with Nasdaq’s listing rule - MSN
Cosmos Health (COSM) Withdraws Registration Statement for Public Offering - GuruFocus
TradingKey - TradingKey
Cosmos Health stock (US22143K1016): Fort18 launch targets $3.2M revenue boost - AD HOC NEWS
Cosmos Health withdraws SEC registration statement - Investing.com UK
Cosmos Health withdraws SEC registration statement By Investing.com - Investing.com South Africa
Cosmos Health Announces Withdrawal of Registration Statement on Form S-1 - ACCESS Newswire
Cosmos Health scraps public offering, pulls SEC registration - Stock Titan
Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months - Digital Journal
[RW] Cosmos Health Inc. SEC Filing - Stock Titan
Men's stamina supplement Fort18 targets $3.2M U.S. sales - Stock Titan
Cosmos Health Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
2.29%
0.00%
자본화:
|
볼륨(24시간):